SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030771
Filing Date
2019-08-08
Accepted
2019-08-08 16:10:04
Documents
95
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akba-10q_20190630.htm 10-Q 3575140
2 EX-10.1 akba-ex101_250.htm EX-10.1 226822
3 EX-10.2 akba-ex102_249.htm EX-10.2 535147
4 EX-10.3 akba-ex103_248.htm EX-10.3 249170
5 EX-10.4 akba-ex104_247.htm EX-10.4 119064
6 EX-31.1 akba-ex311_7.htm EX-31.1 17692
7 EX-31.2 akba-ex312_8.htm EX-31.2 17690
8 EX-32.1 akba-ex321_6.htm EX-32.1 12246
  Complete submission text file 0001564590-19-030771.txt   14770659

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT akba-20190630.xml EX-101.INS 3291448
10 XBRL TAXONOMY EXTENSION SCHEMA akba-20190630.xsd EX-101.SCH 92871
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20190630_cal.xml EX-101.CAL 90233
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20190630_def.xml EX-101.DEF 344882
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20190630_lab.xml EX-101.LAB 635992
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20190630_pre.xml EX-101.PRE 531955
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 191009575
SIC: 2834 Pharmaceutical Preparations